Cargando…
Zinc and COVID-19: Basis of Current Clinical Trials
Coronavirus disease-2019 (COVID-19) pandemic continues to threaten patients, societies, and economic and healthcare systems around the world. Like many other diseases, the host immune system determines the progress of COVID-19 and fatality. Modulation of inflammatory response and cytokine production...
Autores principales: | Pal, Amit, Squitti, Rosanna, Picozza, Mario, Pawar, Anil, Rongioletti, Mauro, Dutta, Atanu Kumar, Sahoo, Sibasish, Goswami, Kalyan, Sharma, Praveen, Prasad, Rajendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580816/ https://www.ncbi.nlm.nih.gov/pubmed/33094446 http://dx.doi.org/10.1007/s12011-020-02437-9 |
Ejemplares similares
-
Microglia and Astrocytes in Alzheimer’s Disease in the Context of the Aberrant Copper Homeostasis Hypothesis
por: Pal, Amit, et al.
Publicado: (2021) -
Molecular basis of quercetin as a plausible common denominator of macrophage-cholesterol-fenofibrate dependent potential COVID-19 treatment axis
por: Pawar, Anil, et al.
Publicado: (2021) -
Zinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy
por: Squitti, Rosanna, et al.
Publicado: (2020) -
Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update
por: Pal, Amit, et al.
Publicado: (2020) -
Evaluation of zinc, copper, and Cu:Zn ratio in serum, and their implications in the course of COVID-19
por: Ivanova, Irena D., et al.
Publicado: (2022)